Back to School: How biopharma can reboot drug development. Access exclusive analysis here

HIV therapeutic vaccine data

The Carlsbad, Calif., company and partner Rhone-Poulenc Rorer Inc. published results of a one-year, Phase II/III trial showing effects in 103 patients on early markers of infection,

The results,

Read the full 290 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE